Monlish et al [11] conducted preliminary studies demonstrating that AMPK is upregulated in human T cells during both an allogeneic human MLR and also following transplantation of human T cells into a xenogeneic model of GVHD in vivo. This evidence concerns the gene PRKAA1 and graft versus host disease.